• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 3. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Methyl 2-bromothiazole-4-carboxylate (CAS No. 170235-26-4): A Key Intermediate in Modern Pharmaceutical Synthesis

Methyl 2-bromothiazole-4-carboxylate (CAS No. 170235-26-4) is a highly versatile and significant compound in the realm of pharmaceutical chemistry. Its molecular structure, featuring both a bromine substituent and a carboxylate ester group, makes it an invaluable intermediate in the synthesis of various biologically active molecules. This compound has garnered considerable attention in recent years due to its role in the development of novel therapeutic agents targeting a wide range of diseases.

The utility of Methyl 2-bromothiazole-4-carboxylate stems from its ability to serve as a precursor in the construction of complex heterocyclic frameworks. Thiazole derivatives, in particular, are well-documented for their pharmacological properties, including antimicrobial, anti-inflammatory, and anticancer activities. The presence of the bromine atom on the thiazole ring enhances its reactivity, allowing for further functionalization through cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These transformations are pivotal in constructing intricate molecular architectures that mimic natural products and exhibit enhanced biological activity.

In recent years, there has been a surge in research focused on developing inhibitors of protein-protein interactions (PPIs) as a strategy to combat various diseases, including cancer and neurodegenerative disorders. Methyl 2-bromothiazole-4-carboxylate has emerged as a crucial building block in the synthesis of small-molecule inhibitors designed to disrupt specific PPIs. For instance, studies have demonstrated its efficacy in generating compounds that target the interaction between Bcl-xL and Bak, which is critical in apoptosis regulation. The bromine substituent facilitates palladium-catalyzed cross-coupling reactions, enabling the introduction of diverse pharmacophores that enhance binding affinity and selectivity.

The pharmaceutical industry has also leveraged Methyl 2-bromothiazole-4-carboxylate in the development of antiviral agents. Viruses often rely on host cellular machinery for replication, making PPIs an attractive target for therapeutic intervention. Researchers have utilized this compound to synthesize molecules that interfere with viral proteins essential for infection and propagation. The carboxylate ester group provides a handle for further derivatization, allowing chemists to fine-tune the properties of these antiviral agents. Notably, derivatives of Methyl 2-bromothiazole-4-carboxylate have shown promising results in preclinical studies against RNA viruses, highlighting its potential as a scaffold for future antiviral drugs.

Beyond its applications in drug discovery, Methyl 2-bromothiazole-4-carboxylate plays a pivotal role in materials science and agrochemical research. Its structural features make it a suitable candidate for designing novel organic semiconductors and ligands for metal-organic frameworks (MOFs). These materials have potential applications in catalysis, gas storage, and separation technologies. Additionally, thiazole derivatives are being explored as bioactive compounds that can protect plants from pathogens and pests. The versatility of Methyl 2-bromothiazole-4-carboxylate as a synthetic intermediate underscores its importance across multiple scientific disciplines.

The synthesis of Methyl 2-bromothiazole-4-carboxylate typically involves multi-step organic transformations starting from readily available precursors. One common approach involves the bromination of thiazole followed by esterification to introduce the carboxylate group. Advances in synthetic methodologies have enabled more efficient and scalable production processes, ensuring a steady supply of this valuable compound for industrial applications. The optimization of these synthetic routes has been accompanied by improvements in purification techniques, resulting in high-purity samples suitable for sensitive biological assays.

In conclusion, Methyl 2-bromothiazole-4-carboxylate (CAS No. 170235-26-4) is a cornerstone compound in modern pharmaceutical synthesis. Its unique structural features and reactivity make it indispensable in the development of therapeutic agents targeting various diseases. From inhibiting PPIs to designing antiviral drugs and exploring new materials, this compound continues to drive innovation across multiple scientific fields. As research progresses, the demand for high-quality Methyl 2-bromothiazole-4-carboxylate is expected to grow, reinforcing its significance in both academic and industrial settings.

• 100367-77-9(Ethyl 2-bromothiazole-4-carboxylate)
• 56355-61-4(methyl 2-bromo-5-methyl-1,3-thiazole-4-carboxylate)
• 5198-88-9(2-bromo-1,3-thiazole-4-carboxylic acid)
• 59418-09-6(Methyl thiazole-4-carboxylate)
• 208264-60-2(Ethyl 2,5-dibromothiazole-4-carboxylate)
• 1053655-63-2(Methyl 2-bromo-5-chlorothiazole-4-carboxylate)
• 914347-25-4(Methyl 2,5-dibromothiazole-4-carboxylate)
• 56355-62-5(Ethyl 2-(2-Bromo-5-methyl-1,3-thiazol-4-yl)acetate)
• 6898-57-3(Ethyl thiazole-4-carboxylate hydrobromide)
• 1228281-54-6(Ethyl 5-amino-2-bromo-1,3-thiazole-4-carboxylate)